Johnson & Johnson Completed Acquisition of V-Wave
On Oct 09, 2024, Johnson & Johnson announced that it successfully completed the acquisition of V-Wave Ltd., a privately-held company dedicated to developing innovative treatments for heart failure patients. V-Wave will now operate under Johnson & Johnson MedTech.
The acquisition of V-Wave strengthens Johnson & Johnson MedTech’s position in the cardiovascular disease space and enhances its ability to address heart failure, one of the most urgent unmet medical needs in healthcare today. This move accelerates the company’s expansion into high-growth, high-potential markets and complements its c...